Therapix Biosciences Ltd. Sponsored ADR
(NASDAQ : TRPX)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
AMGNAmgen Inc.
3.18%201.801.2%$535.45m
GILDGilead Sciences, Inc.
4.38%75.970.9%$479.92m
BIIBBiogen Inc.
2.24%335.771.3%$393.28m
CELGCelgene Corporation
2.74%84.071.2%$348.47m
ILMNIllumina, Inc.
3.65%324.853.5%$308.52m
REGNRegeneron Pharmaceuticals, Inc.
5.47%398.192.6%$240.98m
ALXNAlexion Pharmaceuticals, Inc.
4.69%127.192.0%$225.17m
VRTXVertex Pharmaceuticals Incorporated
4.27%185.241.9%$219.48m
SRPTSarepta Therapeutics, Inc.
4.79%137.6316.4%$179.31m
AAgilent Technologies, Inc.
2.61%67.341.5%$161.58m
BMRNBioMarin Pharmaceutical Inc.
6.08%105.504.4%$143.61m
LGNDLigand Pharmaceuticals Incorporated
5.63%211.3423.3%$121.86m
VKTXViking Therapeutics, Inc.
5.42%14.970.9%$118.11m
NKTRNektar Therapeutics
1.94%50.035.6%$111.16m
EXASExact Sciences Corporation
2.12%67.1725.3%$105.21m

Company Profile

Therapix Biosciences Ltd. is a specialty clinical-stage pharmaceutical company, focused on creating and enhancing a portfolio of technologies and assets based on cannabinoid pharmaceuticals. It initiated two internal drug development programs based on repurposing an FDA approved synthetic cannabinoid (dronabinol): Joint Pharma developing THX-TS01 targeted to the treatment of TS and BrainBright Pharma developing THX-ULD01 targeted to the high value and under-served market of MCIs. The company was founded on August 23, 2004 and is headquartered in Tel Aviv, Israel.